ISCT announces recipients of key 2022 achievement awards in cell and gene therapy Vancouver, Canada, April 07, 2022 - The International Society read more...
ISCT completes focus and program for 2022 Annual Meeting in San Francisco to cover cell and gene therapy ‘ Bench to Bedside to Benefit’ Annual Meeting to provide venue for the entire cell read more...
International Society for Cell & Gene Therapy establishes working group to tackle regulatory and ethical issues with Expanded Access Vancouver, Canada, February 28, 2022 - The International Society read more...
Global partnership takes action to provide urgent training to upskill key personnel Vancouver, Canada, October 18, 2021 , - The International Society for Cell & Gene Therapy (ISCT) and The National read more...
International Society for Cell & Gene Therapy establishes working group to tackle regulatory and ethical issues with Expanded Access Vancouver, Canada, February 28, 2022 - The International read more...
Vancouver, Canada, April 12, 2021 - The International Society for Cell & Gene Therapy (ISCT) , the global society of clinicians, researchers, regulators, technologists, and industry partners dedicated read more...
World Health Organization selects ISCT journal Cytotherapy® to publish novel ATMP official nomenclature initiative Official INN assignments to provide proper classification for ATMPs, ensuring safe dispensing read more...
Vancouver, Canada, March 22, 2021 - The International Society for Cell & Gene Therapy (ISCT) , the global society of clinicians, researchers, regulators, technologists, and industry partners dedicated read more...
ISCT President Bruce Levine receives 2020 Dennis Confer Innovate Award for CAR-T cell therapy achievements Vancouver, Canada, November 9, 2020 - The International Society for Cell & Gene Therapy (ISCT) read more...
Vancouver, Canada, September 14, 2020 - The International Society for Cell & Gene Therapy (ISCT), the global society of clinicians, researchers, regulators, technologists, and industry partners dedicated read more...